Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability

by Mirza, Sameer, Katafiasz, Bryan J., Kumar, Rakesh, Wang, Jun, Mohibi, Shakur, Jain, Smrati, Gurumurthy, Channabasavaiah Basavaraju, Pandita, Tej K., Dave, Bhavana J., Band, Hamid, Band, Vimla
Published 2012

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients

by Zhao, Xiangshan, Mirza, Sameer, Alshareeda, Alaa, Zhang, Ying, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Kim, Jun Hyun, Mohibi, Shakur, Goswami, Monica, Lele, Subodh M., West, William, Qiu, Fang, Ellis, Ian O., Rakha, Emad A., Green, Andrew R., Band, Hamid, Band, Vimla
Published 2012

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

by Mirza, Sameer, Rakha, Emad A., Alshareeda, Alaa, Mohibi, Shakur, Zhao, Xiangshan, Katafiasz, Bryan J., Wang, Jun, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Ellis, Ian O., Green, Andrew R., Band, Hamid, Band, Vimla
Published 2013